Quidel Posts 36 Percent Drop in Q1 Revenues on Weak Flu Season | GenomeWeb

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market Wednesday that its first-quarter revenues fell 36 percent as a weak cold and flu season hit the firm's sales.

The San Diego-based diagnostics company reported total revenues of $38 million for the three-month period ended March 31, compared to $59.6 million for the first quarter of 2011. It fell short of Wall Street's consensus estimate of $40.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.